Matthew Wood
Director of Business Development - Strategic and Industry Partnerships

Matthew Wood is Professor of Neuroscience and Deputy Head of the Medical Sciences Division at the University of Oxford. He directs the Laboratory of RNA biology and Neuromuscular Disease investigating development of RNA-based medicines for neuromuscular disease focusing on the development of advanced generation antisense oligonucleotides for Duchenne muscular dystrophy and related neuromuscular conditions.

He has pioneered the development of novel delivery systems including peptide and exosome-based technologies for the targeted delivery of macromolecular biologics, including oligonucleotides, to tissues including the brain. He is the founder of the biotech spin-outs Evox Therapeutics (developing therapeutic exosome technology) and PepGen (developing peptide based drug delivery technology), is an advisor to numerous research funding agencies including the UK Medical Research Council and is a director of the University of Oxford’s technology transfer organization, Oxford University Innovation.

What's On

More speakers

Barbara Ghinelli

Barbara Ghinelli

Director, Clusters and Harwell Campus Business Development, UKRI-STFC

Henry Snaith

Henry Snaith

Co-founder and Chief Scientific Offer, Oxford PV

Tim Curtis

Tim Curtis

Managing Director, Ricardo Energy & Environment

Stuart Woods

Stuart Woods

Managing Director, Oxford Instruments NanoScience

 

PARTNERS

Visit Britain

Keep in touch

Sign up to the Venturefest Oxford newsletter to make sure you are the first to hear the latest news. The next #vfestox newsletter will be coming out soon! Make sure you're on the list!

 

 

 

 

 

Email Preferences

Make connections that lead to new investments, new businesses and new ideas in the high-tech sector in Oxfordshire.